MeiraGTx Holdings (MGTX) Other Non-Current Liabilities (2017 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Other Non-Current Liabilities came in at $1.4 million in Q4 2025, down 50.41% YoY from $2.8 million in Q4 2024, and up 2.49% on a QoQ basis from $1.4 million in Q3 2025.

MeiraGTx Holdings (MGTX) Other Non-Current Liabilities (2017 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Other Non-Current Liabilities data on file, last reported at $1.4 million in Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 50.41% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (down 50.41% YoY) and the FY2025 annual result came in at $1.4 million, down 50.41% from the prior year.
  • Other Non-Current Liabilities advanced to $1.4 million in Q4 2025, from $1.4 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.9 million in Q3 2024 to a low of $1.3 million in Q1 2025.
  • A 5-year average of $2.1 million and a median of $2.1 million in 2022 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2024 — Other Non-Current Liabilities rose 24.19% — and 2025, when it plunged 52.6%.
  • Tracing MGTX's Other Non-Current Liabilities over 5 years: stood at $2.1 million in 2021, then grew by 4.71% to $2.2 million in 2022, then advanced by 10.19% to $2.4 million in 2023, then increased by 17.49% to $2.8 million in 2024, then plunged by 50.41% to $1.4 million in 2025.
  • The last three Other Non-Current Liabilities figures came in at $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 MeiraGTx Holdings 1.10 Bn 1.03 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.40 Mn
Sep 30, 2025 1.37 Mn
Jun 30, 2025 1.45 Mn
Mar 31, 2025 1.34 Mn
Dec 31, 2024 2.82 Mn
Sep 30, 2024 2.88 Mn
Jun 30, 2024 2.49 Mn
Mar 31, 2024 2.44 Mn
Dec 31, 2023 2.40 Mn
Sep 30, 2023 2.32 Mn
Jun 30, 2023 2.30 Mn
Mar 31, 2023 2.24 Mn
Dec 31, 2022 2.18 Mn
Sep 30, 2022 2.08 Mn
Jun 30, 2022 2.10 Mn
Mar 31, 2022 2.11 Mn
Dec 31, 2021 2.08 Mn
Sep 30, 2021 1.92 Mn
Jun 30, 2021 1.90 Mn
Mar 31, 2021 1.86 Mn